The impact of intranasal corticosteroids in a prospective cohort of children with sleep disordered breathing.

Rowe, K. S., Pinczower, G. D., Nixon, G. M. and Kubba, H. (2024) The impact of intranasal corticosteroids in a prospective cohort of children with sleep disordered breathing. International Journal of Pediatric Otorhinolaryngology, 178, 111899. (doi: 10.1016/j.ijporl.2024.111899) (PMID:38402717)

Full text not currently available from Enlighten.

Abstract

Introduction Sleep disordered breathing (SDB) is common in children and the most common reason for adenotonsillectomy. This large observational cohort study from a specialist outpatient clinic describes the impact of intranasal steroids (INS) on symptom improvement and the need for surgery. Method Observational cohort study of 568 children assessing the impact of INS using the OSA-5 questionnaire with clinical and surgical outcome measures. Results The mean OSA-5 score at first visit was 7.78. Symptoms were persistent for a median 9 months (range 2–72). 51% underwent a trial of INS with 56% reporting symptomatic improvement. The mean score decreased from 8.2 to 5.5 (p < 0.0001) in those prescribed INS. They had a significantly higher symptom load (p < 0.01), turbinate size (p < 0.005) and history of atopy (p < 0.01) than the non-trial group. The rate of surgery in the non-trial group was 56% compared with 38% in those who had INS (p < 0.001). With increasing symptom burden, the reported improvement with INS and comparative reduction in surgery increased. Baseline OSA-5 scores were predictive of rates of surgery. Atopic status or age did not influence response to INS. Conclusion The mean score at first visit and the median duration of symptoms indicated significant persistent symptoms in this cohort. The use of INS improved symptoms of SDB in 56%. The need for surgery in the group that received INS was 38% compared with 56% in those not trialling INS, despite the non-trial group having significantly less symptoms and signs. Symptomatic improvement was not influenced by age or atopic status.

Item Type:Articles
Status:Published
Refereed:Yes
Glasgow Author(s) Enlighten ID:Kubba, Mr Haytham
Authors: Rowe, K. S., Pinczower, G. D., Nixon, G. M., and Kubba, H.
College/School:College of Medical Veterinary and Life Sciences > School of Medicine, Dentistry & Nursing
Journal Name:International Journal of Pediatric Otorhinolaryngology
Publisher:Elsevier
ISSN:0165-5876
ISSN (Online):1872-8464
Published Online:20 February 2024

University Staff: Request a correction | Enlighten Editors: Update this record